RayzeBio
RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. As the emerging leader in radiopharmaceuticals, RayzeBio is developing an innovative robust pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.
HealthcareBioTech
San Diego, CA
$250M-1B
Funding
11-50
Employees
Company Mission
Targeted innovative radiopharmaceuticals for cancer
Looking for a better job?
Discover the best career opportunities with the best company cultures for you.
Do you work at this company?
Connect your business to thousands of engaged professionals in your city and beyond.
